Accrued expenses consist of the following: | | | | | | | | | As of | | | September 30, | | December 31, | | | 2024 | | 2023 | Royalties due to Bioprojet | | $ | 40,295 | | $ | 40,419 | Rebates and other sales deductions | | | 45,837 | | | 38,842 | Interest | | | 2,941 | | | 3,354 | Sales and marketing | | | 3,507 | | | 2,354 | Research and development | | | 8,011 | | | 9,835 | Milestone payments | | | 1,000 | | | — | Professional fees, consulting, and other services | | | 5,241 | | | 2,195 | Other expenses | | | 2,841 | | | 2,495 | | | $ | 109,673 | | $ | 99,494 |
|